COF
63
-4
IFF
53
2
STX
52
-4
IP
70
-3
AON
60
2
VLO
42
2
ABT
57
-5
ETR
68
-3
FOX
57
-3
DUK
50
-2
FLR
48
3
C
62
-3
EFX
41
-2
SIG
47
-2
PAYX
57
-2
GLW
48
-5
PX
73
-6
UHS
54
-4
R
77
2
VZ
42
3
COF
63
-4
IFF
53
2
STX
52
-4
IP
70
-3
AON
60
2
VLO
42
2
ABT
57
-5
ETR
68
-3
FOX
57
-3
DUK
50
-2
FLR
48
3
C
62
-3
EFX
41
-2
SIG
47
-2
PAYX
57
-2
GLW
48
-5
PX
73
-6
UHS
54
-4
R
77
2
VZ
42
3
Financhill
Back

Cassava Sciences Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Sell
34

SAVA
Cassava Sciences

Last Price:
26.28
Seasonality Move:
33.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Buy these stocks BEFORE President Trump returns to the Oval Office

See details on which stocks are poised to surge.

Cassava Sciences Price Quote

$26.28
+1.08 (+4.29%)
(Updated: November 14, 2024 at 11:50 AM ET)

Cassava Sciences Key Stats

Sell
34
Cassava Sciences (SAVA) is a Sell
Day range:
$25.00 - $27.00
52-week range:
$8.79 - $42.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
28.97
P/B ratio:
7.62%
Volume:
1.1M
Avg. volume:
1.5M
1-year change:
29.23%
Market cap:
$1.3B
Revenue:
$0
EPS:
$-1.38

How Much Does Cassava Sciences Make?

Data Unavailable

Is Cassava Sciences Growing As A Company?

Data Unavailable

Cassava Sciences Stock Price Performance

  • Did Cassava Sciences Stock Go Up Last Month?
    Cassava Sciences share price went down by -2.33% last month
  • Did SAVA's Share Price Rise Over The Last Year?
    SAVA share price rose by 29.23% over the past 1 year

What Is Cassava Sciences 52-Week High & Low?

Cassava Sciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cassava Sciences?

  • How Much Debt Does Cassava Sciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Cassava Sciences Have?
    Cash and short term investments quarterly total is $149M
  • What Is Cassava Sciences’s Book Value Per Share?
    Book value per share is 3.47

Is Cassava Sciences Cash Flow Positive?

  • What Is SAVA Cash Flow From Operations?
    Cash flow from operations (TTM) is -$78M
  • What Is Cassava Sciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $124.7M
  • What Is Cassava Sciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$87K

Cassava Sciences Return On Invested Capital

Data Unavailable

Cassava Sciences Earnings Date & Stock Price

Cassava Sciences Competitors

  • Who Are Cassava Sciences's Competitors?
    Below is a list of companies who compete with Cassava Sciences or are related in some way:
    • Adverum Biotechnologies Inc (ADVM)
    • Bristol-Myers Squibb Co (BMY)
    • EyePoint Pharmaceuticals Inc (EYPT)
    • PTC Therapeutics Inc (PTCT)
    • Seelos Therapeutics Inc (SEEL)

Cassava Sciences Dividend Yield

Cassava Sciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 34.09%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 116.00
Upside from Last Price: 360.32%

Major Shareholders

  • How many SAVA shares are owned by institutional investors?
    20.6M SAVA shares are owned by institutional investors
  • How many SAVA shares are owned by insiders?
    2M SAVA shares are owned by insiders